SPRO
Spero Therapeutics·NASDAQ
--
--(--)
--
--(--)
SPRO fundamentals
Spero Therapeutics (SPRO) released its earnings on Mar 26, 2026: revenue was 41.30M (YoY +174.51%), beat estimates; EPS was 0.53 (YoY +239.47%), beat estimates.
Revenue / YoY
41.30M
+174.51%
EPS / YoY
0.53
+239.47%
Report date
Mar 26, 2026
EPS
Actual | -1.22 | -0.85 | -0.86 | -0.68 | -0.66 | -0.63 | -0.7 | -0.9 | -1.01 | -0.87 | -0.33 | 0.55 | -0.25 | -0.23 | -0.06 | 0.96 | -0.24 | -0.33 | -0.32 | -0.38 | -0.25 | -0.03 | -0.13 | 0.53 | |||||||||
Forecast | -1.24 | -1.12 | -0.874 | -0.732 | -0.6267 | -0.75 | -0.6633 | -0.7475 | -0.93 | -0.9267 | -0.3033 | -0.3533 | -0.3333 | -0.3433 | -0.03 | -0.1 | -0.0433 | -0.38 | -0.265 | -0.31 | -0.55 | -0.38 | -0.25 | -0.2 | |||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +1.61% | +24.11% | +1.60% | +7.10% | -5.31% | +16.00% | -5.53% | -20.40% | -8.60% | +6.12% | -8.80% | +255.68% | +24.99% | +33.00% | -100.00% | +1060.00% | -454.27% | +13.16% | -20.75% | -22.58% | +54.55% | +92.11% | +48.00% | +365.00% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.70M | 1.68M | 4.00M | 1.91M | 7.30M | 5.15M | 3.06M | 2.74M | 2.07M | 1.99M | 2.01M | 47.44M | 2.07M | 2.70M | 25.47M | 73.52M | 9.27M | 10.20M | 13.47M | 15.04M | 5.87M | 14.19M | 5.44M | 41.30M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.44M | 3.31M | 3.01M | 3.67M | 3.75M | 4.53M | 4.47M | 4.95M | 1.93M | 1.43M | 5.42M | 866.67K | 1.27M | 1.08M | 14.97M | 18.63M | 21.53M | 4.90M | 23.00M | 12.40M | 11.00M | 11.00M | 12.00M | 26.00M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -50.59% | -49.40% | +32.86% | -48.07% | +94.79% | +13.77% | -31.40% | -44.57% | +7.48% | +39.05% | -62.97% | +5373.96% | +63.34% | +149.23% | +70.20% | +294.58% | -56.96% | +108.10% | -41.44% | +21.32% | -46.60% | +28.99% | -54.65% | +58.83% |
Earnings Call
You can ask Aime
What factors drove the changes in Spero Therapeutics's revenue and profit?What is Spero Therapeutics's gross profit margin?What guidance did Spero Therapeutics's management provide for the next earnings period?What is Spero Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Spero Therapeutics's earnings call?What does Spero Therapeutics do and what are its main business segments?What were the key takeaways from Spero Therapeutics’s earnings call?What is the market's earnings forecast for Spero Therapeutics next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
